Clinical application of transintercostal aortic valve replacement in patients with aortic valve disease

YOU Yang; LIU Chun-xiao; FU Chao; YANG Zhi-hao; LIU Zi-hua; HUANG Zhong-xu; ZHAO Xin

doi:10.3969/j.issn.1672-5301.2025.04.006

Abstract：Objective This article summarizes the clinical data of patients who underwent aortic valve replacement(AVR)through the second intercostal space,aiming to summarize the clinical diagnosis and treatment experience of minimally invasive surgery in the field of cardiac surgery,and to evaluate the clinical application value of AVR through the second intercostal space for the treatment of aortic valve disease.Methods 34 patients admitted to the Second Department of Cardiac Surgery at Qilu Hospital from August 2023 to January 2025 were accepted.All the patients underwent a 5-7 cm transverse incision through the right second intercostal space,and the femoral artery and vein cannulation was established for extracorporeal circulation.The clinical application value of this surgical technique was demonstrated by observing the surgical and postoperative recovery indicators of the patients.Results The average operation time was(220.5±20.2)minutes;the average extracorporeal circulation time was(120.0±25.4)minutes;and the average cross-clamping time was(95.0±15.8)minutes.The patients recovered well postoperatively,with no serious complications.The average postoperative drainage time was(3.0±0.5)days;the average length of stay in the intensive care unit(ICU)was(19.0±6.7)hours;and the average postoperative hospital stay was(6.0±1.2)days.Conclusion AVR through the second intercostal space is a safe and effective minimally invasive procedure that can effectively reduce surgical trauma,shorten recovery time and improve the quality of life of patients,making it suitable for promotion in patients who meet the criteria.